Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)

by palligoelme@gmail.com | Nov 8, 2025 | Clinical Trials

​ Conditions: Dilated Cardiomyopathy (DCM) Interventions: Procedure: Immunoadsorption Sponsors: Wuhan Union Hospital, China Not yet recruiting Conditions: Dilated Cardiomyopathy (DCM) Interventions: Procedure: Immunoadsorption Sponsors: Wuhan Union Hospital, China Not...

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Breast Cancer; Prostate Cancer; Colorectal Cancer; Thyroid Cancer; Breast Cancer Stage III; Breast Cancer Stage IV; Prostate Cancer Stage III; Prostate Cancer Stage IV; Colorectal Cancer Stage III; Colorectal Cancer Stage IV; Thyroid Cancer Stage III;...

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Hidradenitis Suppurativa Interventions: Drug: SAR445399; Drug: Placebo Sponsors: Sanofi Not yet recruiting Conditions: Hidradenitis Suppurativa Interventions: Drug: SAR445399; Drug: Placebo Sponsors: Sanofi Not yet...

mHealth for Early Psychosis Caregivers in Statewide Program Outreach

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Caregiver; Caregiver Distress; Caregiver to a Young Adult With Early Psychosis; Family Caregivers Interventions: Behavioral: Bolster Sponsors: University of North Carolina, Chapel Hill; North Carolina Department of Health and Human Services Not yet...

A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Acute Pain Interventions: Drug: Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion) Sponsors: AFT Pharmaceuticals, Ltd. Not yet recruiting Conditions: Acute Pain Interventions:...

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) – Relapsing-remitting Interventions: Drug: Ublituximab Sponsors: Northwestern University; TG Therapeutics, Inc. Not yet recruiting Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) –...